Related Experiment Video
Updated: Jul 1, 2026
05:31
Disruption of the Mouse Blood-Brain Barrier by Small Extracellular Vesicles from Hypoxic Human Placentas
Published on: January 26, 2024
Novel biomarkers for predicting preeclampsia.
David M Carty1, Christian Delles, Anna F Dominiczak
1BHF Glasgow Cardiovascular Research Centre, University of Glasgow, G12 8TA Glasgow, United Kingdom.
Trends in Cardiovascular Medicine
|September 16, 2008
Summary
Preeclampsia remains a significant global health concern for pregnant individuals. This review explores its causes, potential biomarkers for early detection, and future research directions to improve prediction and diagnosis.
Area of Science:
- Obstetrics and Gynecology
- Perinatal Medicine
- Reproductive Health
Background:
- Preeclampsia is a leading cause of maternal illness and death globally.
- Current methods for predicting preeclampsia before symptom onset are insufficient.
- Understanding pathophysiology is crucial for improving clinical outcomes.
Purpose of the Study:
- To review the underlying pathophysiology of preeclampsia.
- To identify potential biomarkers for early prediction and diagnosis.
- To explore future research avenues for preeclampsia management.
Main Methods:
- Literature review of existing research on preeclampsia pathophysiology.
- Analysis of studies investigating potential predictive and diagnostic biomarkers.
- Discussion of emerging research trends and future directions.
Main Results:
- Preeclampsia pathophysiology involves complex maternal-fetal interactions.
- Several biomarkers show promise for early detection but require further validation.
- Continued research is needed to translate findings into clinical practice.
Conclusions:
- Improved prediction and diagnosis of preeclampsia are critical.
- Biomarker discovery and validation are key research priorities.
- Future research should focus on translating pathophysiological insights into clinical tools.
